Table 1.
Baseline characteristics of the study population.
| Characteristics | Total |
|---|---|
| n | 282 |
| Female sex, (%) | 38.8 |
| Age (Years) | 67.9 ± 6.6 |
| BMI (kg/m2) | 29.4 ± 3.1 |
| Waist circumference (cm) | 101.0 ± 8.5 |
| Type 2 diabetes, (%) | 55.8 |
| Statins use, (%) | 65.6 |
| Physical activity, METs/d | 288.9 ± 266.0 |
| Dyslipidemia, (%) | 68.2 |
| HDL cholesterol (mg/dL) | 51.5 ± 13.4 |
| LDL cholesterol (mg/dL) | 133.3 ± 38.8 |
| Triglycerides (mg/dL) | 148.8 ± 76.0 |
| Smoking % | |
| Current | 19.1 |
| Former | 33.9 |
| Never | 47.0 |
| Inflammatory markers (pg/mL) | |
| IFNγ | 17.7 ± 10.5 |
| IL-6 | 3.9 ± 4.3 |
| IL-8 | 11.6 ± 9.3 |
| IL-10 | 25.4 ± 30.5 |
| IL-1b | 2.3 ± 1.5 |
BMI, body mass index; WC, waist circumference; MET, metabolic equivalent; HDL, High density lipoprotein; LDL, Low density lipoprotein; IFNγ, interferon-gamma; IL, interleukin.